SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-285671
Filing Date
2023-11-30
Accepted
2023-11-30 07:31:00
Documents
13
Period of Report
2023-11-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d401028d8k.htm   iXBRL 8-K 25471
2 EX-99.1 d401028dex991.htm EX-99.1 12640
  Complete submission text file 0001193125-23-285671.txt   161334

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20231130.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20231130_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20231130_pre.xml EX-101.PRE 10837
7 EXTRACTED XBRL INSTANCE DOCUMENT d401028d8k_htm.xml XML 3212
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 231453972
SIC: 2834 Pharmaceutical Preparations